Innate Pharma
Clinical trials sponsored by Innate Pharma, explained in plain language.
-
Immunotherapy duo aims to boost lung cancer cure rates before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether adding two immunotherapy drugs, IPH5201 and durvalumab, to standard chemotherapy before and after surgery can improve outcomes for people with early-stage (stage II to III) non-small cell lung cancer. The study includes two groups: one receiv…
Phase: PHASE2 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cancer drug IPH4502 enters first human tests
Disease control Recruiting nowThis early-stage trial is testing a new drug called IPH4502 in people with advanced solid tumors that have a specific protein called Nectin-4. The main goals are to check the drug's safety and find the best dose. About 145 participants will receive the drug, and researchers will …
Phase: PHASE1 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC